NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.42%
After-hours: Aug 15, 2025, 06:33 PM EDT
NeuroSense Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.61 | -2.93 | -5.69 | -1.3 | -1.02 | 3.08 | -0.97 | -1.73 | -1.14 | -1.73 | -2.81 | -4.14 | -66.64 | -12.25 | -11.91 | -2.65 |
PEG Ratio | 0.25 | -0.02 | 0.07 | -0.02 | 0.00 | -0.03 | -0.02 | n/a | -0.13 | 0.07 | -0.11 | -0.00 | 0.75 | 4.52 | 0.22 | 0.53 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 10.06 | -8.93 | -11.45 | -4.03 | -6.44 | -49.35 | -13.14 | 7.02 | 2.56 | 2.64 | 3.98 | 3.71 | 2.99 | n/a | 47.19 | 34.22 |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 11.38K | n/a | 2.82K | -7.39K | 13.96K | n/a | n/a | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 11.38K | n/a | 2.82K | -7.39K | 13.96K | n/a | n/a | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | -0.01 | -0.02 | -0.01 | -0.08 | -0.43 | -0.07 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | n/a | n/a | n/a | n/a |
Quick Ratio | 2.21 | 0.21 | 0.46 | 0.36 | 0.84 | 1.80 | 2.50 | 2.78 | 6.41 | 10.96 | 15.09 | 11.61 | 19.41 | n/a | 8.21 | n/a |
Current Ratio | 2.21 | 0.21 | 0.46 | 0.26 | 0.84 | 1.82 | 2.52 | 2.80 | 4.28 | 10.96 | 15.09 | 11.42 | 19.12 | n/a | 8.08 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -51.39 | n/a | -1.24 | -3.29K | -241.42 | -1.84 | -9.65 | n/a | -331.9 | -102.57 | -141.91 | n/a | n/a | n/a | -162.38 |
Return on Equity | -0.7 | 0.76 | 0.50 | 0.77 | 1.57 | -4 | 3.38 | -1.01 | -0.56 | -0.38 | -0.35 | -0.22 | -0.01 | n/a | -0.99 | -3.22 |
Return on Assets | -0.39 | -2.18 | -0.47 | -3.74 | -0.93 | 0.15 | -0.66 | -0.55 | -0.41 | -0.32 | -0.3 | -0.19 | -0.01 | n/a | -0.87 | n/a |
Return on Invested Capital | -0.67 | 0.75 | 1.82 | 0.96 | 15.36 | -1.12 | -0.14 | -0.83 | -0.56 | -0.39 | -0.33 | -0.25 | -0.15 | n/a | -1.01 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |